Pneumococcal vaccine status at baseline n=190 492 | Influenza vaccine status at baseline n=190 459 | |||||
---|---|---|---|---|---|---|
Never vaccinated n=79 476 | Vaccinated n=111 016 | Unvaccinated* n=32 552 | Currently vaccinated n=124 130 | Residual 1–5 years n=33 777 | ||
Age (years) | 71 (66–77) | 72 (66–78) | 71 (66–77) | 72 (66–78) | 71 (66–78) | |
Median (IQR) | n (%) | n (%) | n (%) | n (%) | n (%) | |
Female | 40 308 (50.7) | 53 146 (47.9) | 16 603 (51.0) | 60 019 (48.4) | 16 813 (49.8) | |
Socioeconomic status† | ||||||
1 (least deprived) | 13 701 (17.2) | 19 912 (17.9) | 5618 (17.3) | 22 181 (17.9) | 5809 (17.2) | |
2 | 14 666 (18.5) | 19 591 (17.7) | 5799 (17.8) | 22 394 (18.0) | 6058 (17.9) | |
3 | 16 156 (20.3) | 23 329 (21.0) | 6567 (20.2) | 25 957 (20.9) | 6956 (20.6) | |
4 | 17 758 (22.3) | 25 481 (23.0) | 7312 (22.5) | 28 128 (22.7) | 7789 (23.1) | |
5 (most deprived) | 17 195 (21.6) | 22 703 (20.5) | 7256 (22.3) | 25 470 (20.5) | 7165 (21.2) | |
Ethnicity | ||||||
White | 43 357 (54.6) | 63 577 (57.3) | 17 037 (52.3) | 71 268 (57.4) | 18 615 (55.1) | |
South Asian | 1515 (1.9) | 2353 (2.1) | 429 (1.3) | 2606 (2.1) | 833 (2.5) | |
Black | 923 (1.2) | 1167 (1.1) | 343 (1.1) | 1290 (1.0) | 457 (1.4) | |
Other | 636 (0.8) | 717 (0.7) | 225 (0.7) | 860 (0.7) | 267 (0.8) | |
Missing | 33 045 (41.6) | 43 202 (38.9) | 14 518 (44.6) | 48 106 (38.8) | 13 605 (40.3) | |
Residential care | 1697 (2.1) | 3274 (3.0) | 436 (1.3) | 3516 (2.8) | 1016 (3.0) | |
Smoking status | ||||||
Non-smoker | 38 078 (47.9) | 44 713 (40.3) | 15 449 (47.5) | 52 782 (42.5) | 14 543 (43.1) | |
Current smoker | 13 901 (17.5) | 16 439 (14.8) | 6252 (19.2) | 18 327 (14.8) | 5756 (17.0) | |
Ex-smoker | 27 497 (34.6) | 49 864 (44.9) | 10 851 (33.3) | 53 021 (42.7) | 13 478 (39.9) | |
Comorbidities | ||||||
Ischemic heart disease | 18 886 (23.8) | 34 415 (31.0) | 6825 (21.0) | 36 761 (29.6) | 9713 (28.8) | |
Congestive cardiac failure | 5935 (7.5) | 10 018 (9.0) | 2175 (6.7) | 10 721 (8.6) | 3065 (9.1) | |
Hypertension | 46 626 (58.7) | 71 311 (64.2) | 18 644 (57.3) | 78 252 (63.0) | 21 024 (62.2) | |
Cerebrovascular disease | 9714 (12.2) | 14 469 (13.0) | 3612 (11.1) | 16 021 (12.9) | 4540 (13.4) | |
Other dementia | 1437 (1.8) | 1956 (1.8) | 322 (1.0) | 2326 (1.9) | 729 (2.2) | |
Chronic lung disease | 4016 (5.1) | 10 881 (9.8) | 1515 (4.7) | 10 530 (8.5) | 2851 (8.4) | |
Chronic liver disease | 402 (0.5) | 734 (0.7) | 168 (0.5) | 729 (0.6) | 240 (0.7) | |
Steroid use in previous 3 months | 2870 (3.6) | 5560 (5.0) | 1039 (3.2) | 5841 (4.7) | 1544 (4.6) | |
Latest HbA1C status % (mmol/mol) | ||||||
None recorded | 11 202 (14.1) | 10 620 (9.6) | 4872 (15.0) | 13 317 (10.7) | 3627 (10.7) | |
Good <7% (<53) | 34 669 (43.6) | 53 305 (48.0) | 13 621 (41.8) | 58 741 (47.3) | 15 596 (46.2) | |
Intermediate 7–10% (53–86) | 27 935 (35.2) | 41 354 (37.3) | 11 389 (35.0) | 45 383 (36.6) | 12 509 (37.0) | |
Poor >10% (>86) | 5670 (7.1) | 5737 (5.2) | 2670 (8.2) | 6689 (5.4) | 2045 (6.1) | |
Antidiabetes medication history | ||||||
None | 38 755 (48.8) | 50 517 (45.5) | 16 463 (50.6) | 58 195 (46.9) | 14 598 (43.2) | |
Oral | 33 623 (42.3) | 46 949 (42.3) | 13 613 (41.8) | 51 914 (41.8) | 15 031 (44.5) | |
Insulin | 2889 (3.6) | 4136 (3.7) | 1024 (3.2) | 4687 (3.8) | 1314 (3.9) | |
Oral and insulin | 4209 (5.3) | 9414 (8.5) | 1452 (4.5) | 9334 (7.5) | 2834 (8.4) | |
Latest eGFR mL/min/1.73 m2 | ||||||
<30 | 2098 (2.6) | 2986 (2.7) | 767 (2.4) | 3337 (2.7) | 977 (2.9) | |
30–44 | 7558 (9.5) | 10 607 (9.6) | 2932 (9.0) | 11 964 (9.6) | 3254 (9.6) | |
45–59 | 18 678 (23.5) | 25 508 (23.0) | 7337 (22.5) | 29 039 (23.4) | 7806 (23.1) | |
≥60 | 51 142 (64.4) | 71 915 (64.8) | 21 516 (66.1) | 79 790 (64.3) | 21 740 (64.4) | |
History of proteinuria | ||||||
No | 71 095 (89.5) | 94 128 (84.8) | 29 231 (89.8) | 107 212 (86.4) | 28 735 (85.1) | |
Yes | 8381 (10.6) | 16 888 (15.2) | 3321 (10.2) | 16 918 (13.6) | 5042 (14.9) |
*Not vaccinated within the five previous years.
†Index of multiple deprivation quintile for primary care practice.
eGFR, estimated glomerular filtration rate.